San Luis Obispo Tribune: Do COVID vaccines work in people with HIV, cancer or organ transplants? What we know
July 1, 2021
Dr. Dimpy P. Shah, Population Health Sciences/ Mays Cancer Center, was included within a story of the San Luis Obispo Tribune addressing her research in which 94% of the 131 patients in the study produced antibodies three to four weeks after full vacci …
Yahoo!: Do COVID vaccines work in people with HIV, cancer or organ transplants? What we know
July 1, 2021
Dr. Dimpy P. Shah, Population Health Sciences/Mays Cancer Center, was included within a story in Yahoo addressing her research in which 94% of the 131 patients in the study produced antibodies three to four weeks after full vaccination, most of which h …
KSAT 12: What you need to know about the delta variant: University Health’s Dr. Jason Bowling
July 1, 2021
Dr. Jason Bowling, Infectious Diseases, discusses for KSAT 12 audiences the latest developments with the Delta variant and how the Covid-19 vaccines stand up against it; he refers to the partnership between University Health and UT Health San Antonio. …
San Antonio Business Journal: SA cancer center to expand research diversity with national clinical trial
July 1, 2021
Dr. Ruben Mesa, executive director of the Mays Cancer Center, was quoted in this story about the Mays Cancer Center at UT Health San Antonio joining three other institutions to participate in a new Advancing Inclusive Research Site Alliance launched by …
Verywell Health: A powerful straw-like device could cure your hiccups
July 1, 2021
Ali Seifi, MD, an associate professor of neurosurgery in UT Health San Antonio’s Joe R. and Teresa Lozano Long School of Medicine, is quoted in this story about HiccAway. Read story
San Antonio Express-News: Delta variant of coronavirus has reached San Antonio, and it’s spreading
July 1, 2021
Dr. Jason E. Bowling, an infectious disease specialist at UT Health San Antonio, was quoted in this story about the COVID-19 delta variant spreading in San Antonio. Read story
KSAT 12: 94% of cancer patients respond well to COVID-19 vaccine in UT Health San Antonio study
July 1, 2021
Dimpy P. Shah, MD, PhD, of the Mays Cancer Center, was quoted in a story about a study that shows nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose. Read s …
Nearly all patients with cancer respond well to COVID-19 vaccines
July 1, 2021
In a U.S. and Swiss study, nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose, but the fact that a small group of the patients exhibited no response raised questions about how their protection against the virus will be addressed moving forward.
94% of patients with cancer respond well to COVID-19 vaccines
June 30, 2021
Small subsets of high-risk patients produce few or no antibodies, however. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (June 30, 2021) — In a U.S. and Swiss study, nearly all patients with cancer developed good immune response …
New employee spotlight: Eduardo Gomez named director of strategic intelligence
June 30, 2021
As UT Health San Antonio expands its overall enterprise throughout the community, including the new UT Health San Antonio Multispecialty and Research Hospital, Eduardo Gomez, MBA, MSc, is expected to play a key role in its success. Gomez joined the institution in May as the inaugural director of strategic intelligence.